{
    "Trade/Device Name(s)": [
        "iTAg MHC Tetramer-CMV",
        "iTAg MHC Tetramer CMV assay"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K051122",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKZ"
    ],
    "Summary Letter Date": "August 1, 2005",
    "Summary Letter Received Date": "May 2, 2005",
    "Submission Date": "April 29, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.5220"
    ],
    "Regulation Name(s)": [
        "Automated differential cell counter"
    ],
    "Analyte Class(es)": [
        "immunology",
        "transplant"
    ],
    "Analyte(s)": [
        "CMV-specific CD8+ lymphocytes"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD FACSCalibur flow cytometer",
        "BCI EPICS-XL flow cytometer",
        "BCI FC500 flow cytometer"
    ],
    "Method(s)/Technology(ies)": [
        "Flow cytometry"
    ],
    "Methodologies": [
        "Enumeration of cell subsets",
        "Identification of lymphocyte populations"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter iTAg MHC Tetramer-CMV assay to enumerate CMV-specific CD8+ lymphocytes using flow cytometry in whole blood.",
    "Indications for Use Summary": "For identification and enumeration of cytomegalovirus (CMV)-specific CD8+ lymphocytes in whole blood by flow cytometry and assessment of CMV-specific immune status and risk of CMV reactivation in immunosuppressed stem cell transplant recipients with specific HLA types.",
    "fda_folder": "Hematology"
}